Congress Stock Trading Ban 2026: Trump Calls for Action, But Don't Hold Your Breath

In his 2026 State of the Union address, President Trump did something unexpected: he called on Congress to pass legislation banning members from trading individual stocks. The chamber applauded. Both sides stood up. It was a bipartisan feel-good moment.

It was also the latest in a long series of moments where everyone in Washington agrees that congressional stock trading is a problem, and then absolutely nothing changes.

Here's what's actually happening with the congress stock trading ban in 2026, who's still making suspicious trades, and why the odds of real reform remain slim.

The Restore Trust in Congress Act: A New Bipartisan Push

The latest legislative attempt is the Restore Trust in Congress Act, introduced by Rep. Chip Roy (R-TX) and Rep. Seth Magaziner (D-RI). The bill would ban members of Congress, their spouses, and their dependent children from buying or selling individual stocks while in office.

The mechanics are straightforward:

• Full ban on individual stock trades for members, spouses, and dependents
• Required divestiture into blind trusts, broad-market index funds, or Treasury securities
• Real penalties for violations, not the current $200 slap on the wrist
• No exceptions for "pre-planned" trades or other loopholes

Roy and Magaziner represent opposite ends of the political spectrum, which is the point. This isn't a partisan issue. The American public overwhelmingly supports a trading ban regardless of party affiliation. The problem has never been public opinion. It's been the 535 people who would have to vote to restrict their own portfolios.

Trump's State of the Union Moment

Trump's call for action during the State of the Union gave the issue its highest-profile endorsement yet. A sitting president, speaking to a joint session of Congress, explicitly telling them to pass a stock trading ban. The applause was bipartisan and enthusiastic.

But presidential rhetoric and legislative action are very different things. Trump didn't endorse a specific bill. He didn't outline consequences for inaction. He gave the issue a headline, which matters for public pressure but means little without a mechanism to force a vote.

Congressional leadership in both chambers controls what gets to the floor. And the people in those leadership positions have historically shown zero urgency on this issue, regardless of who occupies the White House.

Meanwhile, the Trades Keep Coming

While Congress debates whether to ban trading, the trades themselves continue at a steady clip. Two recent examples illustrate why the public remains skeptical.

Senator Mullin's Carpenter Technology Trade

On February 4, 2026, Senator Markwayne Mullin (R-OK) purchased up to $50,000 worth of Carpenter Technology (CRS), a specialty metals manufacturer that supplies the aerospace and defense industries. The timing raised immediate questions.

Carpenter Technology's stock rallied in the weeks following Mullin's purchase, driven by defense-related contract news and increased government spending signals. Mullin sits on the Senate Armed Services Committee, giving him direct access to information about defense procurement priorities and budget allocations.

Was the trade based on insider knowledge? There's no way to prove it from public filings alone. But the pattern is familiar: a member with committee oversight of a specific sector makes a well-timed trade in that sector. It happens often enough that "coincidence" becomes a harder explanation to accept.

Pelosi's AllianceBernstein Position

Nancy Pelosi remains the most-watched trader in Congress, and for good reason. In January 2026, disclosure filings revealed that Pelosi purchased 25,000 shares of AllianceBernstein (AB), the global asset management firm.

AllianceBernstein manages over $700 billion in assets and has significant exposure to markets that are directly influenced by federal monetary and regulatory policy. Pelosi, as a senior member of the House, has access to economic briefings and policy discussions that the average investor does not.

The Pelosi trades have become almost a meme in retail investing circles, with "Pelosi tracker" accounts on social media drawing millions of followers. But the humor masks a serious point: if the public can see these trades and recognize the informational advantage, the fact that Congress hasn't acted to stop them tells you everything about their actual priorities.

Why the Ban Keeps Failing

Every session of Congress since the STOCK Act was passed in 2012 has seen at least one bill introduced to ban congressional stock trading. The PELOSI Act, the TRUST Act, the Ban Congressional Trading Act, the ETHICS Act. The names change. The result doesn't.

The structural problem is simple: Congress has to vote to restrict Congress. There is no external body that can impose this rule. The executive branch can't mandate it. The Supreme Court won't touch it. It requires a majority of members to voluntarily give up a significant financial benefit.

The most common objections from opponents:

• "It discourages talented people from serving." Members of Congress earn $174,000 per year with full benefits, a pension, and significant influence. The talent pool is fine.
• "Members have the same rights as citizens." Citizens don't sit in classified briefings about defense contracts, pharmaceutical regulations, or trade policy before making their trades.
• "Blind trusts are sufficient." Current blind trust rules are voluntary and rarely used. The "blind" part is generous, given that members choose the trustee and often know the general composition of the trust.

The real reason is less philosophical: many members of Congress are wealthy, many actively trade, and many have outperformed the market by margins that would make hedge fund managers jealous. Passing a ban would cost them real, personal money.

What Happens Next

The Restore Trust in Congress Act will likely follow the same path as its predecessors. It will get media coverage. It will get bipartisan co-sponsors. It might even get a committee hearing. But without pressure from leadership to bring it to a floor vote, it will expire at the end of the session.

Trump's endorsement adds a new variable. If he continues to push the issue publicly, it becomes harder for Republican leadership to bury the bill without looking like they're defying their own president. But Trump has a long list of legislative priorities, and a stock trading ban is unlikely to stay near the top for long.

The most realistic path to passage isn't a single dramatic vote. It's sustained public pressure that makes the political cost of inaction higher than the financial cost of compliance. We're not there yet, but the conversation is louder than it's ever been.

What This Means for Investors

Until the ban passes (if it ever does), congressional trading data remains one of the most underused signals in the market. The 45-day disclosure delay limits its usefulness for short-term trading, but for identifying sector-level conviction and medium-term thesis trades, the data is remarkably informative.

When members of the Armed Services Committee load up on defense stocks, that's a directional signal. When the Finance Committee members shift out of banking, that's worth investigating. The trades are public record. The pattern recognition is where the edge lives.

The irony is clear: the same informational advantage that makes congressional trading ethically questionable is exactly what makes the data valuable to outside investors. As long as Congress keeps trading, we'll keep tracking.

Related: The PELOSI Act: Will Congress Actually Ban Stock Trading? | This Week's Congress Trades | How to Track Congress Stock Trades